GSK962040

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	4

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 4 of 4 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2011-004438-32-DE (EUCTR)	23/10/2013	13/08/2013	The effect of repeat doses of GSK962040on the pharmacokinetics of L-DOPA in subjects with Parkinson’ ...	A randomized, double-blind, placebo-controlled, parallel group, dose ranging study to assess the eff ...	Investigate the ability of the motilin receptor agonist GSK962040to improve levodopa pharmacokinetic ...	Product Name: GSK962040 Product Code: GSK962040 INN or Proposed INN: GSK962040 Other descriptive name: ...	GlaxoSmithKline Research and Development Limited	NULL	Not Recruiting			Female: yes Male: yes	70		Australia;Germany;United Kingdom;Sweden
2	EUCTR2011-004438-32-SE (EUCTR)	26/08/2013	01/07/2013	The effect of repeat doses of GSK962040on the pharmacokinetics of L-DOPA in subjects with Parkinson’ ...	A randomized, double-blind, placebo-controlled, parallel group, dose ranging study to assess the eff ...	Investigate the ability of the motilin receptor agonist GSK962040to improve levodopa pharmacokinetic ...	Product Name: GSK962040 Product Code: GSK962040 INN or Proposed INN: GSK962040 Other descriptive name: ...	GlaxoSmithKline Research and Development Limited	NULL	Not Recruiting			Female: yes Male: yes	70		Australia;Germany;United Kingdom;Sweden
3	NCT01602549 (ClinicalTrials.gov)	July 2012	17/5/2012	A Study to Assess the Effect of Repeat Doses of GSK962040on the Pharmacokinetics of L-DOPA in Subjec ...	A Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Assess the Eff ...	Gastroparesis	Drug: GSK962040 (25 mg tablet);Drug: Placebo	GlaxoSmithKline	NULL	Completed	40 Years	80 Years	All	58	Phase 2	Australia;Germany;Sweden;United Kingdom
4	EUCTR2011-004438-32-GB (EUCTR)	25/04/2012	18/04/2012	The effect of repeat doses of GSK962040on the pharmacokinetics of L-DOPA in subjects with Parkinson’ ...	A randomized, double-blind, placebo-controlled, parallel group, dose ranging study to assess the eff ...	Investigate the ability of the motilin receptor agonist GSK962040to improve levodopa pharmacokinetic ...	Product Name: GSK962040 Product Code: GSK962040 INN or Proposed INN: GSK962040 Other descriptive name: ...	GlaxoSmithKline Research and Development Limited	NULL	Not Recruiting			Female: yes Male: yes	70	Phase 2	Germany;United Kingdom;Sweden

First Previous1Next Last